Whois & Analysis for latuda.com

Lurasidone (trade name Latuda) is an atypical antipsychotic developed by Dainippon Sumitomo Pharma and marketed by Sunovion in the USA.

It has been approved for treatment of schizophrenia by the FDA since 2010.

In the USA since 2013, it is also approved for the treatment of depressive episodes associated with bipolar I disorder as well as bipolar II disorder in adults when used alone or in combination with lithium, valproate, or lamotrigine.

Bipolar disorder, also known as manic depression, is a mental disorder that causes periods of depression and periods of elevated mood.

The elevated mood is significant and is known as mania or hypomania, depending on its severity, or whether symptoms of psychosis are present.

During mania, an individual behaves or feels abnormally energetic, happy, or irritable.

Individuals often make poorly thought out decisions with little regard to the consequences.

The need for sleep is usually reduced during manic phases.

During periods of depression, there may be crying, a negative outlook on life, and poor eye contact with others.

The risk of suicide among those with the illness is high at greater than 6 percent over 20 years, while self-harm occurs in 30–40 percent.

Other mental health issues such as anxiety disorders and substance use disorder are commonly associated.

Therapy (often abbreviated tx, Tx, or Tx) is the attempted remediation of a health problem, usually following a diagnosis.

In the medical field, it is usually synonymous with treatment (also abbreviated tx or Tx).

Among psychologists and other mental health professionals, including psychiatrists, psychiatric nurse practitioners, and clinical social workers, the term may refer specifically to psychotherapy (sometimes dubbed 'talking therapy').

The English word therapy comes via Latin therapīa from and literally means "curing" or "healing".

A symptom (from Greek σύμπτωμα, "accident, misfortune, that which befalls", from συμπίπτω, "I befall", from συν- "together, with" and πίπτω, "I fall") is a departure from normal function or feeling which is noticed by a patient, reflecting the presence of an unusual state, or of a disease.

A symptom is subjective, observed by the patient, and cannot be measured directly, whereas a sign is objectively observable by others.

For example, paresthesia is a symptom (only the person experiencing it can directly observe their own tingling feeling), whereas erythema is a sign (anyone can confirm that the skin is redder than usual).

Symptoms and signs are often nonspecific, but often combinations of them are at least suggestive of certain diagnoses, helping to narrow down what may be wrong.

In other cases they are specific even to the point of being pathognomonic.

Adolescence is a transitional stage of physical and psychological development that generally occurs during the period from puberty to legal adulthood (age of majority).

Adolescence is usually associated with the teenage years, but its physical, psychological or cultural expressions may begin earlier and end later.

For example, puberty now typically begins during preadolescence, particularly in females.

Physical growth (particularly in males), and cognitive development can extend into the early twenties.

Thus age provides only a rough marker of adolescence, and scholars have found it difficult to agree upon a precise definition of adolescence.